These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 16890283)
1. Predisposition to therapy-related acute leukemia with balanced chromosomal translocations does not result from a major constitutive defect in DNA double-strand break end joining. Coiteux V; Onclercq-Delic R; Fenaux P; Amor-Guéret M Leuk Res; 2007 Mar; 31(3):353-8. PubMed ID: 16890283 [TBL] [Abstract][Full Text] [Related]
2. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements. Andersen MK; Johansson B; Larsen SO; Pedersen-Bjergaard J Haematologica; 1998 Jun; 83(6):483-8. PubMed ID: 9676019 [TBL] [Abstract][Full Text] [Related]
3. Chromatin structural elements and chromosomal translocations in leukemia. Zhang Y; Rowley JD DNA Repair (Amst); 2006 Sep; 5(9-10):1282-97. PubMed ID: 16893685 [TBL] [Abstract][Full Text] [Related]
4. Therapy-related acute leukemia associated with involvement of 11q23 after high grade non-Hodgkin lymphoma. Martinelli G; Testoni N; Zinzani PL; Biondi A; Cimino G; Tura S Haematologica; 1998 Mar; 83(3):283-4. PubMed ID: 9573684 [TBL] [Abstract][Full Text] [Related]
5. The role of nonhomologous DNA end joining, conservative homologous recombination, and single-strand annealing in the cell cycle-dependent repair of DNA double-strand breaks induced by H(2)O(2) in mammalian cells. Frankenberg-Schwager M; Becker M; Garg I; Pralle E; Wolf H; Frankenberg D Radiat Res; 2008 Dec; 170(6):784-93. PubMed ID: 19138034 [TBL] [Abstract][Full Text] [Related]
6. DNA topoisomerase II in therapy-related acute promyelocytic leukemia. Mistry AR; Felix CA; Whitmarsh RJ; Mason A; Reiter A; Cassinat B; Parry A; Walz C; Wiemels JL; Segal MR; Adès L; Blair IA; Osheroff N; Peniket AJ; Lafage-Pochitaloff M; Cross NC; Chomienne C; Solomon E; Fenaux P; Grimwade D N Engl J Med; 2005 Apr; 352(15):1529-38. PubMed ID: 15829534 [TBL] [Abstract][Full Text] [Related]
7. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature. Betancourt-García RD; Castro J; Fernández AC; López-Enríquez A; Fradera J; Pacheco E P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558 [TBL] [Abstract][Full Text] [Related]
8. [Chromosome translocations and leukemias induced by inhibitors of topoisomerase II anticarcinogenic drugs]. Dassonneville L; Bailly C Bull Cancer; 1998 Mar; 85(3):254-61. PubMed ID: 9752316 [TBL] [Abstract][Full Text] [Related]
9. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans. Larson RA; Le Beau MM Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816 [TBL] [Abstract][Full Text] [Related]
10. Effects of camptothecin on double-strand break repair by non-homologous end-joining in DNA mismatch repair-deficient human colorectal cancer cell lines. Jacob S; Miquel C; Sarasin A; Praz F Nucleic Acids Res; 2005; 33(1):106-13. PubMed ID: 15642697 [TBL] [Abstract][Full Text] [Related]
11. Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells. de Campos-Nebel M; Larripa I; González-Cid M Mutat Res; 2008 Nov; 646(1-2):8-16. PubMed ID: 18812179 [TBL] [Abstract][Full Text] [Related]
12. Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair. Sallmyr A; Fan J; Rassool FV Cancer Lett; 2008 Oct; 270(1):1-9. PubMed ID: 18467025 [TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-related secondary leukemias: A role for DNA repair by error-prone non-homologous end joining in topoisomerase II - Induced chromosomal rearrangements. Kantidze OL; Razin SV Gene; 2007 Apr; 391(1-2):76-9. PubMed ID: 17234368 [TBL] [Abstract][Full Text] [Related]
14. Type II topoisomerases--inhibitors, repair mechanisms and mutations. Heisig P Mutagenesis; 2009 Nov; 24(6):465-9. PubMed ID: 19762349 [TBL] [Abstract][Full Text] [Related]
15. Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22q23) positive AML patient and review of literature. Piccaluga PP; Martinelli G; Malagola M; Rondoni M; Bianchini M; Visani G; Baccarani M Haematologica; 2003 Aug; 88(8):ECR28. PubMed ID: 12935987 [No Abstract] [Full Text] [Related]
16. Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia. Lin P; Medeiros LJ; Yin CC; Abruzzo LV Cancer Genet Cytogenet; 2006 Apr; 166(1):82-5. PubMed ID: 16616115 [TBL] [Abstract][Full Text] [Related]
18. Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia. Snijder S; Mellink CH; van der Lelie H Cancer Genet Cytogenet; 2008 Jan; 180(2):149-52. PubMed ID: 18206542 [TBL] [Abstract][Full Text] [Related]
19. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia? Larson RA Best Pract Res Clin Haematol; 2007 Mar; 20(1):29-37. PubMed ID: 17336252 [TBL] [Abstract][Full Text] [Related]
20. DNA double strand break repair inhibition as a cause of heat radiosensitization: re-evaluation considering backup pathways of NHEJ. Iliakis G; Wu W; Wang M Int J Hyperthermia; 2008 Feb; 24(1):17-29. PubMed ID: 18214766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]